WEST LAFAYETTE, Ind., April 24, 2014 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy in cancer and other serious diseases, today announced that the company will host a conference call on Thursday, May 1, at 4:30 p.m. EDT to discuss its first quarter 2014 financial results and provide an operational update.
Help employers find you! Check out all the jobs and post your resume.
